![Michael I. D'Angelica, MD](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/node/148/image/d-angelica-michael.jpg?h=10d202d3)
Michael I. D'Angelica, MD, FACS
Hepatopancreatobiliary Surgeon
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Hepatobiliary Surgery
- Gallbladder & Bile Duct Cancers
- Liver Cancer
Meet Surgeon Michael D’Angelica
Request an Appointment
About Me
- Enid A. Haupt Chair in Surgery
- Director, Hepatopancreatobiliary Fellowship Program
- Director, Surgical Oncology Fellowship Program
- Vice Chair, Education
As a surgical oncologist, I care for patients with benign and malignant (cancerous) diseases of the liver, bile duct, gallbladder, and pancreas. Many patients come to me with cancer that has spread (metastasized) from the colon to the liver. I also have an interest in benign pancreatic tumors, which do not necessarily merit immediate removal but should be carefully watched for any changes that warrant surgery.
The tumors that I treat are uncommon, and many forms were once thought to be incurable. But because of innovative research, largely done at Memorial Sloan Kettering Cancer Center, and my close collaboration with our radiologists and medical oncologists, I can often offer patients a good chance at long-term survival and, in many cases, cure.
Our team of eight board-certified surgeons performs approximately 1,000 operations a year for hepatopancreatobiliary (HPB)-related disease.
Read more
At MSK, I am honored to hold the Enid A. Haupt Chair in Surgery and serve as the Vice-Chair of Education in the Department of Surgery. I have also been elected as the president of the medical staff, where I co-chair the Hospital Quality Assurance Committee and chair our medical staff advisory council. I am Program Director for two prestigious training fellowships in Surgical Oncology and Hepatopancreatobiliary Surgery. Externally, I am Vice Chair of the National Comprehensive Cancer Network (NCCN) panel on Clinical Practice Guidelines in Hepatobiliary Cancers. For years, I have worked closely with the NCCN to help shape and write these treatment guidelines that are today followed in the United States and much of the world.
I have continued to be an active researcher, and since 1996, I have published more than 450 peer-reviewed journal articles. I am currently leading national prospective clinical trials that address important issues in our field.
I am and have been an invited member of the editorial board for many academic journals, including Annals of Surgery, Surgery, Annals of Surgical Oncology, the Journal of Gastrointestinal Surgery, Langenbeck’s Archives of Surgery, Digestive Surgery, and Hepatic Oncology. I am currently an associate editor of the HPB journal. I also have served as a reviewer for dozens of other specialty journals. In addition, I am an active member of many medical societies, in which I’ve held many leadership positions, including president of the Americas Hepato-Pancreato-Biliary Association (AHPBA). I have had the great honor of lecturing both nationally and internationally at more than 250 institutions and conferences for these and other organizations worldwide. In collaboration with MSK colleagues, I have been an editor on Surgical Management of Hepatobiliary and Pancreatic Disorders and many editions of Blumgart’s Surgery of the Liver, Biliary Tract, and Pancreas.
I became a cancer surgeon in part because I find cancer a complicated and fascinating disease, but also because surgery is an exciting — and constantly evolving — treatment tool. Now, nearly two decades into my career, I find that what I value most are the relationships I have with my patients — working with them, often for many years, to find the best way to fight their disease with their particular needs and lifestyle in mind. Outside of work, I am a self-proclaimed family man and spend my free time with my wife and children.
A hepatopancreatobiliary (heh-PA-toh-PAN-kree-A-to-BIH-lee-AYR-ee) surgeon is a doctor with special training in surgery on the liver, pancreas, gallbladder, and bile ducts. They are also called an HPB surgeon.
My Specialties
- Hepatobiliary Surgery
- Gallbladder & Bile Duct Cancers
- Liver Cancer
- Pancreatic Cancer
- Gastrointestinal Neuroendocrine Tumors
- Adrenal Tumors
Education
- MD, Tufts University School of Medicine
Residencies
- General Surgery - University of Connecticut
Awards and Honors
- Castle Connolly: America’s Top Doctor (2024)
- Top Doctors New York Metro Area, Castle Connolly (2023)
- Castle Connolly: America's Top Doctors (2023)
- Castle Connolly: New York Magazine Top Doctors (2016-2020)
Fellowships
- Surgical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Surgery
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
![Women talking](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/paragraph/131881/cta_image/app-220128-006_rt_1200x800.jpeg?h=10d202d3)
New Patients
Current Patients
Contact and Location
Dr. D'Angelica sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
![Smiling doctors in the lab](/themes/mskcc/images/clinicaltrials_small.png)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. D'Angelica’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Michael I. D'Angelica discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].